$572 Million Decision Against Johnson & Johnson in Landmark Opioid Trial by JAN HOFFMAN


The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits.

Published: August 26, 2019 at 02:00AM

from NYT Health https://ift.tt/2Zrl5WP